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Letter from editor-in-Chief
Dear Readers,
This is my great privilege to deliver to you the very first issue of Arterial 
Hypertension that I have been entrusted the responsibility for. 
Facing the expiry of term of the former Editor-in-Chief Professor Krystyna 
Widecka, Board of Polish Society of Hypertension accepted my vision and 
plans focused on our Journal development. Within the next 4 years I will 
strive to vastly improve visibility of our Journal, and to make way for further 
indexations in large databases. 
I cordially invite the authors from Poland and neighboring countries to dis-
seminate your work via our platform. This will not only help to strengthen our position but also facilitate 
tightening our bonds on the scientific grounds. 
As I reviewed all articles published in Arterial Hypertension for the last three years I believe that some 
valuable works have still a very strong citation potential. I therefore encourage the authors to bring them 
back to light and cite them upon closest convenient occasion. Of more, back in 2019 two essential docu-
ments were publicized in Arterial Hypertension i.e.: Polish Society of Hypertension official guidelines 
on the management of hypertension, and the position paper coordinated by three influential medical 
societies. The latter comprehensively clarifies aspects of hypertension management in pregnancy. I kindly 
invite you to recollect these extremely important statements, what has been made easy for you, as both 
are open access documents. Therefore, including these references in your manuscripts would be of huge 
benefit for our Journal. 
Taking this rare opportunity of a first letter from Editor-in-Chief I would like to share just one closing 
remark with you.  I want to warmly invite you to start or continue the cooperation with us. It is very 
likely that with your even minimal input we can get wider visibility in the world’s scientific community. 
Let’s make this happen, together.
Jacek Wolf, M.D., Ph.D.
Editor-in-Chief ‘Arterial Hypertension’
March 31, 2021
